Instrument Inactif

Autres langues Nunzia Pharmaceutical Corporation Other OTC

Actions

NUNZ

US67097W1027

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/11/22
Nunzia Pharmaceutical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	03/10/22
Nunzia Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	03/10/22
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23/05/22
Nunzia Pharmaceutical Company Reports Earnings Results for the First Quarter Ended March 31, 2022	23/05/22
NUNZIA PHARMACEUTICAL CO MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	15/04/22
Nunzia Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	15/04/22
Nunzia Pharmaceutical Company Auditor Raises 'Going Concern' Doubt	15/04/22
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)	29/03/22
Nunzia Pharmaceutical Company Auditor Raises 'Going Concern' Doubt	29/03/22
Nunzia Pharmaceutical : Annual Report Late filing	28/03/22
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	18/03/22
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	02/03/22
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	10/11/21
Nunzia Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	10/11/21
NUNZIA PHARMACEUTICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	16/09/21
Nunzia Pharmaceutical Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020	16/09/21
NUNZIA PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/09/21
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	17/08/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Nunzia Pharmaceutical Corporation Other OTC

Actions

NUNZ

US67097W1027

Autres langues

Filtres